Table 3 Clinical features of the two subtypes of MAFLD in the GSE89632 dataset
From: Contribution of classification based on ferroptosis-related genes to the heterogeneity of MAFLD
| Â | 1 | 2 | p |
|---|---|---|---|
n | 35 | 28 | Â |
Steatosis (%) | Â | Â | 0.047 |
 < 0.3 | 25 (71.4) | 13 (46.4) |  |
 0.3–0.6 | 7 (20.0) | 10 (35.7) |  |
 > 0.6 | 3 (8.6) | 5 (17.9) |  |
Fibrosis (%) | Â | Â | 0.224 |
 0 | 15 (42.9) | 16 (57.1) |  |
 1 | 10 (28.6) | 7 (25.0) |  |
 2 | 4 (11.4) | 2 (7.1) |  |
 3 | 3 (8.6) | 2 (7.1) |  |
 4 | 3 (8.6) | 1 (3.6) |  |
Lobular inflammation (%) | Â | 0.192 | Â |
 0 | 14 (40.0) | 16 (57.1) |  |
 1 | 10 (28.6) | 6 (21.4) |  |
 2 | 7 (20.0) | 4 (14.3) |  |
 3 | 4 (11.4) | 2 (7.1) |  |
Ballooning (%) | Â | Â | 0.158 |
 0 | 19 (54.3) | 20 (71.4) |  |
 1 | 11 (31.4) | 6 (21.4) |  |
 2 | 5 (14.3) | 2 (7.1) |  |
NAS (%) | Â | Â | 0.025 |
 0 | 6 (17.1) | 3 (10.7) |  |
 1 | 5 (14.3) | 2 (7.1) |  |
 2 | 5 (14.3) | 3 (10.7) |  |
 3 | 6 (17.1) | 2 (7.1) |  |
 4 | 5 (14.3) | 4 (14.3) |  |
 5 | 3 (8.6) | 3 (10.7) |  |
 6 | 3 (8.6) | 4 (14.3) |  |
 7 | 1 (2.9) | 5 (17.9) |  |
 8 | 1 (2.9) | 2 (7.1) |  |
Age =  > 60 (%) | 2 (5.7) | 0 (0.0) | 0.498 |
Sex = M (%) | 19 (54.3) | 15 (53.6) | 0.955 |